Company intelligence / Profile preview

Kannalife Sciences

Doylestown, Pennsylvania, United States
Ownership
Private
Development stage
Other
01

Overview

Kannalife's lead candidate KLS-13019 has demonstrated improved potency, safety, and bioavailability compared to cannabidiol in pre-clinical models of chemotherapy-induced peripheral neuropathy and neurodegenerative conditions. No clinical data are yet reported, but the program is IND-enabling and supported by multiple NIH grants, with ongoing preclinical validation for neuroprotection and pain management[1][2][3][7].

Therapeutic areas
OncologyNeurologyDermatologyGastroenterology
Modalities
Small moleculeSynthetic cannabinoid
Industry
Biotech
02

Drug pipeline

1 asset

Cannatol

Unknown
03

Partnerships

National Institutes of Health (NIH)National Institute of Neurological Disorders and Stroke (NINDS)National Institute on Drug Abuse (NIDA)Biotech Inc. (South Park Ventures joint venture)The Michael J. Fox Foundation

Beyond the preview

Go deeper on Kannalife Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kannalife Sciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call